Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Juan I. Barrasa"'
Autor:
Sandra Pérez-Baos, Paula Gratal, Juan I. Barrasa, Ana Lamuedra, Olga Sánchez-Pernaute, Gabriel Herrero-Beaumont, Raquel Largo
Publikováno v:
Journal of Inflammation, Vol 16, Iss 1, Pp 1-10 (2019)
Abstract Background In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling, we sought synovial activation of STATs and their end-products, along with their modification with tofacitinib (TO
Externí odkaz:
https://doaj.org/article/f1f2c5026ee1484a90187c322d192105
Publikováno v:
International Journal of Molecular Sciences, Vol 14, Iss 2, Pp 2652-2683 (2013)
Annexins constitute an evolutionary conserved multigene protein superfamily characterized by their ability to interact with biological membranes in a calcium dependent manner. They are expressed by all living organisms with the exception of certain u
Externí odkaz:
https://doaj.org/article/005876d36e2048a8a61dcc94052d2842
Development of multicellular animals requires epigenetic repression by Polycomb group proteins. The latter assemble in multi-subunit complexes, of which two kinds, Polycomb Repressive Complex 1 (PRC1) and Polycomb Repressive Complex 2 (PRC2), act tog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6db0eaf97a64dfedf2fa8c2adc6affa
https://doi.org/10.1101/2023.01.12.523763
https://doi.org/10.1101/2023.01.12.523763
Autor:
Tatyana G. Kahn, Juan I. Barrasa, Sarina R Cameron, Yuri B. Schwartz, Soumyadeep Nandi, Per Stenberg
Publikováno v:
Journal of Biological Chemistry. 293:14342-14358
Polycomb group proteins are essential epigenetic repressors. They form multiple protein complexes of which two kinds, PRC1 and PRC2, are indispensable for repression. Although much is known about their biochemical properties, how mammalian PRC1 and P
Autor:
Raquel Largo, I. Prieto-Potin, S. Perez-Baos, A. Larrañaga-Vera, Gabriel Herrero-Beaumont, Juan I. Barrasa, P. Gratal
Publikováno v:
British Journal of Pharmacology. 174:3018-3031
BACKGROUND AND PURPOSE Patients with active rheumatoid arthritis (RA) have increased cardiovascular mortality, paradoxically associated with reduced circulating lipid levels. The Janus kinase (Jak) inhibitor tofacitinib ameliorates systemic and joint
Autor:
Olga Sánchez-Pernaute, Gabriel Herrero-Beaumont, S. Perez-Baos, Ana Lamuedra, Raquel Largo, P. Gratal, Juan I. Barrasa
Publikováno v:
Journal of Inflammation (London, England)
Journal of Inflammation, Vol 16, Iss 1, Pp 1-10 (2019)
Journal of Inflammation, Vol 16, Iss 1, Pp 1-10 (2019)
Background In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling, we sought synovial activation of STATs and their end-products, along with their modification with tofacitinib (TOFA), at f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2244f12bb57de69c84cc6e6950dbbf61
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156597
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-156597
Autor:
Sarina R, Cameron, Soumyadeep, Nandi, Tatyana G, Kahn, Juan I, Barrasa, Per, Stenberg, Yuri B, Schwartz
Publikováno v:
The Journal of biological chemistry. 293(37)
Polycomb group proteins are essential epigenetic repressors. They form multiple protein complexes of which two kinds, PRC1 and PRC2, are indispensable for repression. Although much is known about their biochemical properties, how mammalian PRC1 and P
Autor:
Ane Larrañaga Vera, Iván Prieto Potin, P. Gratal, Sandra Pérez Baos, Gabriel Herrero Beaumont, Affiliations: Bone, Juan I. Barrasa, Raquel Largo
Publikováno v:
IBJ Plus.
Autor:
Juan I. Barrasa, Tatyana G. Kahn, Soumyadeep Nandi, Sarina R Cameron, Per Stenberg, Yuri B. Schwartz
Polycomb Group proteins are essential epigenetic repressors. They form multiple protein complexes of which two kinds, PRC1 and PRC2, are indispensable for repression. Although much is known about their biochemical properties, how PRC1 and PRC2 are ta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f072a1ffeb8ae1afd80f6d183513e7c3
https://doi.org/10.1101/177097
https://doi.org/10.1101/177097
Autor:
Juan I. Barrasa, A. Larrañaga-Vera, I. Prieto-Potin, S Pérez Baos, Raquel Largo, P. Gratal, Gabriel Herrero-Beaumont
Publikováno v:
Poster Presentations.
Background Patients with active rheumatoid arthritis (RA) have increased cardiovascular mortality, paradoxically associated with reduced serum lipid levels. In fact, an inverse relationship between C-reactive protein (CRP) and circulating lipid level